Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study

BACKGROUND: The gold standard of HER2 status assessment in breast cancer is still debated. Immunohistochemistry (IHC) and in-situ technology as fluorescent-labeled methodology (FISH) can be influenced by pre-analytical factors, assay-conditions and interpretation of test results. We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Zsuzsanna, Noske, Aurelia, Ramach, Constanze, Padberg, Barbara, Moch, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879657/
https://www.ncbi.nlm.nih.gov/pubmed/24377754
http://dx.doi.org/10.1186/1471-2407-13-615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879657/
https://www.ncbi.nlm.nih.gov/pubmed/24377754
http://dx.doi.org/10.1186/1471-2407-13-615

Ejemplares similares